Answers are grounded in this paper and cite their sources.
Study demonstrates improved antibacterial activity in CuO:rGO nanocomposites against Escherichia coli and Staphylococcus aureus, suggesting innovative biomedical applications.
Copper oxide/reduced graphene oxide (CuO:rGO) nanocomposites were synthesized through an eco‐friendly, cost‐effective, and time‐efficient green route using Myristica Fragrans Houtt (nutmeg) leaf extract as both reducing and capping agent. The presence of the (002) plane of rGO along with the reduced intensity of CuO peaks confirms the successful integration of CuO nanoparticles onto rGO layers. The absence of impurity peaks or phytochemical signals indicates the high purity of the nanocomposites and further validated by FTIR analysis. FESEM images show CuO forming large clusters of smaller spherical particles, while CuO:rGO images reveal nanoparticles anchored to rGO sheets, suggesting improved aggregation control. HRTEM analysis corroborates the structural and morphological findings. UV–Vis DRS spectra reveal a band gap reduction from 1.89 eV (CuO) to 1.64 eV (CuO:rGO), signifying enhanced optical charge transfer. PL analysis shows defect‐related peaks, which are advantageous for antibacterial activity. Agar well diffusion tests demonstrate superior antibacterial efficacy of CuO:rGO nanocomposites against bacterial pathogens including Escherichia coli ( E. coli ), Bacillus cereus ( B. cereus ), Bacillus subtilis ( B. subtilis ), Staphylococcus epidermidis ( S. epidermidis ), and Staphylococcus aureus ( S. aureus ), compared to pure rGO and CuO. These results highlight the strong potential of CuO:rGO nanocomposites in biomedical applications.
No takes yet. Share an insight, caveat, or question.
Nandagopalan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: